Sanna Ristimäki

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

A Bayesian reanalysis of the Standard versus Accelerated Initiation of Renal-Replacement Therapy in Acute Kidney Injury (STARRT-AKI) trial

Max C. Richardson, Jun Yu Li, Kelly A. Fusco, 2022, Critical Care.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

Max C. Richardson, Kelly A. Fusco, Troy H. Campbell, 2022, Intensive Care Medicine.

Environmental Education in Rural Development : A Case Study in Mecubúri District, Mozambique

M. Elfving, Sanna Ristimäki, 2011 .

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Kelly A. Fusco, L. Forni, S. Bagshaw, 2024, Critical care explorations.

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Kelly A. Fusco, L. Forni, S. Bagshaw, 2023, Intensive Care Medicine.